Cargando…

Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)

INTRODUCTION: Compression is the mainstay of treatment for venous leg ulcers (VLUs) and there are few effective adjuvant treatments. There is only observational evidence supporting the use of hypochlorous acid (HOCl) as a topical wound solution on VLU and some limited randomised evidence for the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jull, Andrew, Wadham, Angela, Bullen, Chris, Parag, Varsha, Parsons, John G M, Laking, George, Waters, Jill, Klonizakis, Markos, O'Brien, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896607/
https://www.ncbi.nlm.nih.gov/pubmed/33602710
http://dx.doi.org/10.1136/bmjopen-2020-043420
_version_ 1783653573213552640
author Jull, Andrew
Wadham, Angela
Bullen, Chris
Parag, Varsha
Parsons, John G M
Laking, George
Waters, Jill
Klonizakis, Markos
O'Brien, Jane
author_facet Jull, Andrew
Wadham, Angela
Bullen, Chris
Parag, Varsha
Parsons, John G M
Laking, George
Waters, Jill
Klonizakis, Markos
O'Brien, Jane
author_sort Jull, Andrew
collection PubMed
description INTRODUCTION: Compression is the mainstay of treatment for venous leg ulcers (VLUs) and there are few effective adjuvant treatments. There is only observational evidence supporting the use of hypochlorous acid (HOCl) as a topical wound solution on VLU and some limited randomised evidence for the effect of a prescribed regimen of exercise. METHODS AND ANALYSIS: The Factorial4VLU trial is a pragmatic, blinded, factorial randomised controlled trial, with 380 participants receiving either a prescribed exercise regimen compared with usual care and either active HOCl wound solution or placebo wound solution at each dressing change for up to 24 weeks. All participants will receive compression therapy. The primary outcome is the proportion of participants with healed VLU at 12 weeks after randomisation as adjudicated by blinded review of ulcer photographs. Secondary outcomes are proportion healed at 24 weeks, time to healing, estimated change in ulcer area, change in 2-Minute Walk Test, change in health-related quality of life, incidence of infection and incidence of all-cause adverse events. If either of the interventions shows a statistically significant positive difference on healing outcomes, cost-effectiveness will be modelled using a health service perspective. ETHICS AND DISSEMINATION: The Factorial4VLU trial received ethical approval from the Northern B Health and Disability Ethics Committee. We plan to publish the results within 1 year of trial completion and will include the results on the trial registration page. TRIAL REGISTRATION NUMBERS: Australia and New Zealand Clinical Trials Register (http://www.anzctr.org.au) (ACTRN12620000116921); Universal Trial Number (WHO) (U1111-1236-2997).
format Online
Article
Text
id pubmed-7896607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78966072021-03-05 Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU) Jull, Andrew Wadham, Angela Bullen, Chris Parag, Varsha Parsons, John G M Laking, George Waters, Jill Klonizakis, Markos O'Brien, Jane BMJ Open Nursing INTRODUCTION: Compression is the mainstay of treatment for venous leg ulcers (VLUs) and there are few effective adjuvant treatments. There is only observational evidence supporting the use of hypochlorous acid (HOCl) as a topical wound solution on VLU and some limited randomised evidence for the effect of a prescribed regimen of exercise. METHODS AND ANALYSIS: The Factorial4VLU trial is a pragmatic, blinded, factorial randomised controlled trial, with 380 participants receiving either a prescribed exercise regimen compared with usual care and either active HOCl wound solution or placebo wound solution at each dressing change for up to 24 weeks. All participants will receive compression therapy. The primary outcome is the proportion of participants with healed VLU at 12 weeks after randomisation as adjudicated by blinded review of ulcer photographs. Secondary outcomes are proportion healed at 24 weeks, time to healing, estimated change in ulcer area, change in 2-Minute Walk Test, change in health-related quality of life, incidence of infection and incidence of all-cause adverse events. If either of the interventions shows a statistically significant positive difference on healing outcomes, cost-effectiveness will be modelled using a health service perspective. ETHICS AND DISSEMINATION: The Factorial4VLU trial received ethical approval from the Northern B Health and Disability Ethics Committee. We plan to publish the results within 1 year of trial completion and will include the results on the trial registration page. TRIAL REGISTRATION NUMBERS: Australia and New Zealand Clinical Trials Register (http://www.anzctr.org.au) (ACTRN12620000116921); Universal Trial Number (WHO) (U1111-1236-2997). BMJ Publishing Group 2021-02-18 /pmc/articles/PMC7896607/ /pubmed/33602710 http://dx.doi.org/10.1136/bmjopen-2020-043420 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Nursing
Jull, Andrew
Wadham, Angela
Bullen, Chris
Parag, Varsha
Parsons, John G M
Laking, George
Waters, Jill
Klonizakis, Markos
O'Brien, Jane
Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title_full Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title_fullStr Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title_full_unstemmed Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title_short Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
title_sort prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (factorial4vlu)
topic Nursing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896607/
https://www.ncbi.nlm.nih.gov/pubmed/33602710
http://dx.doi.org/10.1136/bmjopen-2020-043420
work_keys_str_mv AT jullandrew prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT wadhamangela prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT bullenchris prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT paragvarsha prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT parsonsjohngm prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT lakinggeorge prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT watersjill prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT klonizakismarkos prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu
AT obrienjane prescribedexerciseregimenversususualcareandhypochlorousacidwoundsolutionversusplacebofortreatingvenouslegulcersstudyprotocolforarandomisedcontrolledtrialfactorial4vlu